Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPs® 7630 in Hand, Foot and Mouth Disease
NCT06353477Phase 3Completed
- Sponsor
- Eskişehir Osmangazi University
- Start
- Jun 2019
- Primary completion
- Jun 2022
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 3 trial of pelargonium sidoides extract in HIV-associated central nervous system involvement (HAND), sponsored by Eskişehir Osmangazi University. Started Jun 2019; status: completed.
02
Drugs
pelargonium sidoides extract
03
Conditions
HIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT06353477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06353477.